PE20140200A1 - Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol - Google Patents

Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol

Info

Publication number
PE20140200A1
PE20140200A1 PE2013000829A PE2013000829A PE20140200A1 PE 20140200 A1 PE20140200 A1 PE 20140200A1 PE 2013000829 A PE2013000829 A PE 2013000829A PE 2013000829 A PE2013000829 A PE 2013000829A PE 20140200 A1 PE20140200 A1 PE 20140200A1
Authority
PE
Peru
Prior art keywords
sodium
gosipol
weight
carboximethyl
carboximethylcellulose
Prior art date
Application number
PE2013000829A
Other languages
English (en)
Inventor
Felix Ivanovich Ershov
Vladimir Georgievich Nesterenko
Abdushukur Abdukhalilovich Sarymsakov
Natalia Uryevna Alekseeva
Original Assignee
Ltd Liability Company Nearmedic Plus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltd Liability Company Nearmedic Plus filed Critical Ltd Liability Company Nearmedic Plus
Publication of PE20140200A1 publication Critical patent/PE20140200A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/10Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
    • C08B11/12Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

METODO DE PRODUCCION DE UN COPOLIMERO DE CARBOXIMETILCELULOSA SODICA CON UN GRADO DE SUSTITUCION DE 0,35 A 0,80 Y GOSIPOL, DE FORMULA 1, DONDE: a ES 1; b ES 3 A 6; c ES 5 A 7; n ES 40 A 50; CON UN PESO MOLECULAR DE 120.000-130.000. DICHO METODO COMPRENDE HACER REACCIONAR UNA DISOLUCION ACUOSA DE CARBOXIMETILCELULOSA SODICA CON UNA DISOLUCION ACUOSA DE ACIDO PERYODICO O PERYODATO DE SODIO MIENTRAS SE HACE PASAR DIOXIDO DE CARBONO HASTA ALCANZAR UN pH de 3,0 A 4,5, AISLAR DIALDEHIDO-CARBOXIMETILCELULOSA, TRATAR EL PRODUCTO RESULTANTE CON GOSIPOL O ACIDO ACETICO-GOSIPOL Y LUEGO CON UNA DISOLUCION ALCALINA ACUOSA, AISLAR EL PRODUCTO MEDIANTE PRECIPITACION CON UN DISOLVENTE ORGANICO. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) 10% A 16% EN PESO DE PRINCIPIO ACTIVO DE FORMULA 1, b) 10% A 20 % EN PESO DE ALIMIDON, c) 0.6% A 0.8% EN PESO DE ESTEARATO DE CALCIO O MAGNESIO
PE2013000829A 2010-10-11 2011-10-06 Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol PE20140200A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010141697/05A RU2453559C1 (ru) 2010-10-11 2010-10-11 Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями

Publications (1)

Publication Number Publication Date
PE20140200A1 true PE20140200A1 (es) 2014-02-21

Family

ID=45938511

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000829A PE20140200A1 (es) 2010-10-11 2011-10-06 Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol

Country Status (26)

Country Link
US (1) US9078916B2 (es)
EP (1) EP2628754B8 (es)
JP (1) JP5690944B2 (es)
CN (1) CN103189393B (es)
AU (1) AU2011314406B2 (es)
BR (1) BR112013008888B1 (es)
CA (2) CA2896450A1 (es)
CL (2) CL2013000962A1 (es)
CO (1) CO6731081A2 (es)
CY (1) CY1119413T1 (es)
DK (1) DK2628754T3 (es)
EA (2) EA024810B1 (es)
EC (1) ECSP13012613A (es)
ES (1) ES2643167T3 (es)
GE (1) GEP201706607B (es)
HR (1) HRP20171330T1 (es)
HU (1) HUE034920T2 (es)
LT (1) LT2628754T (es)
PE (1) PE20140200A1 (es)
PL (1) PL2628754T3 (es)
PT (1) PT2628754T (es)
RS (1) RS56257B1 (es)
RU (1) RU2453559C1 (es)
SI (1) SI2628754T1 (es)
UA (2) UA108126C2 (es)
WO (1) WO2012050483A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2499002C1 (ru) * 2012-06-14 2013-11-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе
RU2577539C2 (ru) * 2014-06-17 2016-03-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе
RU2754067C2 (ru) * 2018-05-18 2021-08-25 Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение
RU2746504C1 (ru) * 2020-02-27 2021-04-14 Ниармедик Интернэшнл Лимитед Противомикробные средства на основе бета-глюканов, способы их получения и применения
JP7207364B2 (ja) 2020-05-19 2023-01-18 Jfeスチール株式会社 ロッドミルのロッド交換装置及び方法
CN114622407B (zh) * 2022-04-01 2023-09-19 浙江隆腾医用新材料有限公司 一种羧甲基纤维素钠纤维的洗脱方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2002755C1 (ru) * 1991-02-04 1993-11-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием
RU2222548C2 (ru) * 2000-07-21 2004-01-27 Зао "Ниармедик Плюс" Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе
JP4445853B2 (ja) * 2002-06-10 2010-04-07 ワイス エルエルシー 新規o−デスメチルベンラファクシンギ酸塩
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
RU2238122C1 (ru) * 2003-01-20 2004-10-20 Ооо "Ниармедик Плюс" Противоинфекционный фармацевтический препарат
RU2270708C1 (ru) * 2004-05-26 2006-02-27 Ооо "Ниармедик Плюс" Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний
US20060144723A1 (en) * 2004-11-02 2006-07-06 Mary Fuller Device for securing valuables
US20070003621A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Dosage forms for movement disorder treatment
US20090285865A1 (en) * 2008-05-14 2009-11-19 Shalaby Shalaby W Palatable, solid oral formulations for male chemical sterilization

Also Published As

Publication number Publication date
UA108975C2 (uk) 2015-06-25
CA2811583C (en) 2016-03-22
US9078916B2 (en) 2015-07-14
CO6731081A2 (es) 2013-08-15
AU2011314406B2 (en) 2016-08-11
AU2011314406A1 (en) 2013-05-23
UA108126C2 (uk) 2015-03-25
WO2012050483A1 (ru) 2012-04-19
CL2013000962A1 (es) 2013-12-06
CY1119413T1 (el) 2018-03-07
PL2628754T3 (pl) 2017-12-29
EA031316B1 (ru) 2018-12-28
EA201690544A1 (ru) 2016-07-29
EA201390530A1 (ru) 2013-07-30
ES2643167T3 (es) 2017-11-21
RU2010141697A (ru) 2012-04-20
CA2896450A1 (en) 2012-04-19
GEP201706607B (en) 2017-01-25
EP2628754A4 (en) 2014-03-26
JP2013540866A (ja) 2013-11-07
US20130266534A1 (en) 2013-10-10
SI2628754T1 (en) 2017-11-30
LT2628754T (lt) 2017-11-10
CN103189393B (zh) 2015-09-30
RU2453559C1 (ru) 2012-06-20
EP2628754A1 (en) 2013-08-21
RS56257B1 (sr) 2017-11-30
EP2628754B8 (en) 2017-10-25
HRP20171330T1 (hr) 2017-10-20
CN103189393A (zh) 2013-07-03
HUE034920T2 (en) 2018-03-28
CA2811583A1 (en) 2012-04-19
CL2015001180A1 (es) 2015-08-28
DK2628754T3 (da) 2017-11-20
JP5690944B2 (ja) 2015-03-25
PT2628754T (pt) 2017-10-19
EA024810B1 (ru) 2016-10-31
ECSP13012613A (es) 2013-10-31
BR112013008888A2 (pt) 2016-06-28
BR112013008888B1 (pt) 2021-01-05
EP2628754B1 (en) 2017-07-12

Similar Documents

Publication Publication Date Title
PE20140200A1 (es) Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol
MY156938A (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
AU2018236805B2 (en) Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
MX2020005956A (es) Sales organicas de acido sulfonico de esteres de aminoacidos y proceso para su preparacion.
EA201591639A1 (ru) Обработка гидроксикарбоновых кислот с получением полимеров
MY158663A (en) Fermentation broth formulations
MY183859A (en) Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
NZ603762A (en) Production of soluble protein solutions from pulses
UA105229C2 (uk) Фармацевтичний склад
MX2013003034A (es) Lactamas piperidinilo-substituidas como moduladores de gpr119.
AU2013328639A8 (en) Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
BR112012028766A2 (pt) processo para a preparação de complexos de insulina e zinco
BR112013000282A2 (pt) derivados do ácido (2-arilóxi-acetilamino)-fenil-propiônico, método para produzir o mesmo e a utilização dos mesmos como produtos farmacêuticos
MX2010008051A (es) Nuevos derivados de fluoroglicosidos aromaticos, productos farmaceuticos que comprenden dichos compuestos y uso de los mismos.
CY1115590T1 (el) Σουλφοξιμινυποκατεστημενα παραγωγα ανιλινοπυριμιδινης ως cdk-αναστολεις, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
AR063747A1 (es) Definilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas
NZ602450A (en) Agomelatine hydrochloride hydrate and preparation thereof
NZ593787A (en) Lyophilised dabigatran
AR088963A1 (es) Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina
BR112013018298A2 (pt) compostos para a redução da produção de beta-amiloides
AR082965A1 (es) Metodo de preparacion de amidas de acido hialuronico altamente sustituidas
GEP20156312B (en) Improved process for preparing soluble granules of salts of pyridine – carboxylic acids
MX2013003581A (es) Proceso para producir granulos que comprende una o mas sales de agentes complejas.
PE20121481A1 (es) Formulacion de liberacion sostenida
EA200900836A1 (ru) Способ получения высокочистой внутренней соли 3-карбокси-n,n,n-триметил-1-пропанаминий гидроксида

Legal Events

Date Code Title Description
FG Grant, registration